US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
AL

ALGNStockAlign Technology, Inc.

Nasdaq Global Select Market · Healthcare · US

$142.71 last close 2026-10-09
Open in terminalCompare
Alert

Verdicts genuinely change. Free email alert the moment ALGN's does — no target price to set, unlike "Alert" above.

Sharia status
NOT YET SCREENED
Not screened yet — no methodology has been established for this symbol
🕌 Held by HLAL · MNZL

Methodology breakdown computing — it will appear here on its own.

🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No active setup right now. The technical picture doesn't show a clear edge — check back when the trend or momentum shifts.

Trade plan

Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.

CANDLE · SCALP
Entry
$178.18
Stop
$177.65
Target
$178.83
Risk : Reward 1.2R

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure1 of 5 timeframes bullish · 91.3% aligned
VWAPPrice holding above VWAP ($140.85)
VolumeRelative volume 4.7× the 20-day average
Momentum10-day rate of change -4.0%
Market & analysts
Wall Street consensus
BUY
25 analysts · worsening
Institutional own.
105.2% *
of shares
Momentum (10d)
-4.0%
rate of change
SMC grade
C · 63
91.3% aligned
🕌 HLAL, MNZL
Held by real halal ETF(s)
0.40% *
Purification ratio (secondary provider, uncertain)
C · 63
SMC grade — 91.3% timeframe alignment
-4.0%
Rate of change (10d)
BUY ↘
Wall Street consensus (25) — worsening
105.2%
Institutional ownership *

🕌 In-house Compliance Research

Computing the full ratio and business-activity breakdown for ALGN — this runs off the critical path so the page paints first. It will appear here on its own.

Tracked investors holding ALGN
InvestorFirmPositionWeightAs of
Ray Dalio Bridgewater Associates $14M 0.1% 2026-06-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

197.51180.24162.97145.70128.432025-10-132026-04-142026-10-09

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
135.94
S2
137.00
S1
139.01
PIVOT
140.07
R1
142.08
R2
143.14
R3
145.15

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
134.74 – 158.82
±8.2% from 146.78, made 2026-09-26 · resolves 2026-10-03
STRONG SELL
from 19 indicators
61.9% of our last 5789 forecasts landed inside their stated range, and 49.9% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG SELL
19 indicators
OscillatorsSTRONG SELL
1 buy · 4 neutral · 2 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)39.50NEUTRAL
Stochastic %K (14)29.03NEUTRAL
CCI (20)-85.66NEUTRAL
Williams %R (14)-70.97NEUTRAL
MACD (12,26,9)0.20BUY
ROC (10)-2.77SELL
Momentum (10)-4.07SELL
EMA (10)143.14SELL
SMA (10)142.92SELL
EMA (20)146.19SELL
SMA (20)145.88SELL
EMA (30)149.31SELL
SMA (30)149.19SELL
EMA (50)154.39SELL
SMA (50)157.00SELL
EMA (100)160.68SELL
SMA (100)165.23SELL
EMA (200)162.05SELL
SMA (200)169.83SELL

About Align Technology, Inc.

Healthcare · Medical Instruments & Supplies

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

aligntech.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Latest Signal — 2026-07-21

CANDLE
Type · SCALP
178.18
Entry
177.65
Stop
178.83
Target
LOSS
Outcome

Stop 177.65 Now 142.71 Target 178.83

Grade verdict

Average — needs more confirmation before sizing up

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 64
⏰ 4H BEARISH 36
🕐 1H BEARISH 98
⏱ 15-Min BULLISH 130
⏲ 5-Min BEARISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-4.0%
Rate of change (10d)
4.7×
Volume vs its 20-day average
-4.52
MACD (no fresh cross)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NEUTRAL   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-10-06 · Asset managers net 906615 (+2612)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.